| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
|
|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-4,242.8500 | -3,087.8400 | -1,809.8790 | -908.6340 |
|
Exploration Expenses
|
0 | -18.6360 | -21.7420 | -35.9960 |
|
Research and Development Expenses
|
-41.7120 | -159.9500 | -104.2650 | -115.8630 |
| Depreciation, Amortization and Depletion
|
-79.4920 | -77.4110 | -78.4060 | -42.5740 |
|
Operating Income/Expenses
|
-4,364.0540 | -3,343.8370 | -2,014.2920 | -1,103.0670 |
|
Total Operating Profit/Loss
|
-4,364.0540 | -3,343.8370 | -2,014.2920 | -1,103.0670 |
| Total Net Finance Income/Expense
|
23.4900 | 16.5920 | 10.4800 | 14.5480 |
| Net Investment Income
|
-6.1950 | -6.0690 | -10.6320 | -2.5600 |
| Irregular Income/Expenses
|
-150.2980 | -122.8300 | -319.5370 | -5.9870 |
|
Other Income/Expense, Non-Operating
|
-1,337.4410 | -1,337.4410 | 0 | -- |
|
Non-Operating Income/Expenses, Total
|
-1,470.4440 | -1,449.7480 | -319.6890 | 6.0010 |
|
Pretax Income
|
-5,834.4980 | -4,793.5850 | -2,333.9810 | -1,097.0660 |
|
Net Income from Continuing Operations
|
-5,834.4980 | -4,793.5850 | -2,333.9810 | -1,097.0660 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-5,834.4980 | -4,793.5850 | -2,333.9810 | -1,097.0660 |
|
Net Income after Non-Controlling/Minority Interests
|
-5,834.4980 | -4,793.5850 | -2,333.9810 | -1,097.0660 |
|
Net Income Available to Common Stockholders
|
-5,834.4980 | -4,793.5850 | -2,333.9810 | -1,097.0660 |
|
Diluted Net Income Available to Common Stockholders
|
-5,834.4980 | -4,793.5850 | -2,333.9810 | -1,097.0660 |
| Basic EPS
|
-0.09 | -0.09 | -0.05 | -0.02 |
| Diluted EPS
|
-0.09 | -0.09 | -0.05 | -0.02 |
|
Basic Weighted Average Shares Outstanding
|
61,422.3510 | 53,035.8040 | 45,386.8900 | 45,386.8900 |
|
Diluted Weighted Average Shares Outstanding
|
61,422.3510 | 53,035.8040 | 45,386.8900 | 45,386.8900 |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-5,857.9880 | -4,810.1770 | -2,344.4610 | -1,111.6140 |
|
EBITDA
|
-5,778.4960 | -4,732.7660 | -2,266.0550 | -1,069.0400 |
|
Normalized EBITDA
|
-5,630.3240 | -3,988.0080 | -1,931.0360 | -1,065.8420 |
|
Normalized Income
|
-5,686.3260 | -4,048.8270 | -1,998.9620 | -1,093.8680 |
|
Total Unusual Items
|
148.1720 | 744.7580 | 335.0190 | 3.1980 |
|
Total Unusual Items Excluding Goodwill
|
148.1720 | 744.7580 | 335.0190 | 3.1980 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 |
12/31/2023 - 11/4/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade